Pepdexpepdex
Stack
โ„– 018

5-Amino-1MQ

An experimental fat-loss compound. An NNMT inhibitor that targets the enzyme driving metabolic stagnation in obesity, with animal and in-vitro data only and no published human results.

Fat Loss
Evidence: Anecdotal

5-Amino-1MQ: An experimental fat-loss compound. An NNMT inhibitor that targets the enzyme driving metabolic stagnation in obesity, with animal and in-vitro data only and no published human results. 5-Amino-1MQ blocks an enzyme called NNMT that gets overactive in obesity and stalls fat loss.

FDA โ“˜
Not approved
WADA
Not banned
Typical dose
50-150 mg orally
Half-life โ“˜
~6-8 hours
Route โ“˜
Oral
Schedule
Once or twice daily
In plain English

5-Amino-1MQ blocks an enzyme called NNMT that gets overactive in obesity and stalls fat loss. Oral capsule. Early human data is promising but limited, best treated as a metabolic adjunct, not a hero.

Status & legalityWhat do these mean? โ†’
Natty? โ“˜
Not natty
FDA โ“˜
Not approved

Not FDA approved. In early human trials.

Compounding โ“˜
Not classified

Not formally categorized in the FDA bulks lists.

WADA โ“˜
Not listed
Prescribed โ“˜

Not prescribed in conventional medicine.

Who it's for

  • โ†’Users in a stalled cut
  • โ†’Plateau-broken stacks late in a diet phase
  • โ†’People with sluggish metabolic markers

What to expect

  1. Week 1

    Subtle. Some users report energy bump.

  2. Week 4

    Body comp shifts in stacked-with-diet users.

  3. Week 8

    Plateau. Cycle off.

Looking at 5-Amino-1MQ? Your next 3 steps

  1. 1Work out your syringe units

    Vial size + BAC water turns into the exact units to draw for 5-Amino-1MQ.

    Open calculator โ†’
  2. 2See what to stack & monitor

    The companion supplements and the bloodwork worth tracking on this kind of protocol.

    Bloodwork guide โ†’
  3. 3Save it & ask the Coach

    A free account gets you Coach questions every day, free; membership saves your stack and makes the Coach stack-aware.

    Create free account โ†’

How it works (mechanism)

Selective inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme overexpressed in obese adipose tissue. NNMT inhibition restores cellular methylation balance and unblocks fat metabolism.

Dosing protocol

Members only

Stacks well with

Members only

Side effects

01GI upset early
02Mild restlessness / energy at higher doses

When NOT to use

  • โš No long term human safety data, short cycles only
  • โš Pregnancy / nursing

Bloodwork to monitor

  • โ€ข Liver enzymes baseline + week 8 (limited data, monitor)

Common mistakes

  • โ€ข Treating it as a primary fat-loss agent rather than a metabolic adjunct
  • โ€ข Running long cycles without the safety data to back it
  • โ€ข Expecting GLP-class results

What it actually is

5-Amino-1MQ is a small molecule, not a peptide, that blocks an enzyme called NNMT. It is taken orally. The interest comes from a genuinely elegant piece of biology: NNMT activity rises in the fat tissue of obese animals, and blocking it in those animals reduces fat mass without changing how much they eat. No human trial of it has been published.

NNMT consumes nicotinamide, a form of vitamin B3, and in doing so drains a pool the cell would otherwise use to make NAD+, the molecule at the centre of energy metabolism. Blocking NNMT is proposed to leave more NAD+ available and to raise the rate at which fat cells burn fuel rather than store it. In obese mice this reduces fat mass. It has also been shown to reactivate ageing muscle stem cells in culture, which is where the secondary longevity claims come from.

Forms, and which is which

Oral capsulesHow all use happens

Dosed daily, often split. It is orally active by design, which is its main practical appeal.

Verdict: The standard form, unregulated supply.

Powder for self-cappingCost

Requires accurate weighing at the tens-of-milligrams scale. Most kitchen scales cannot do it.

Verdict: Cheap, with the dosing error on you.

Blends with NAD+ precursorsMarketing

Sold as NAD+ stacks on the shared mechanism. Combines a compound with no human data with supplements whose own human data is thin.

Verdict: Several unknowns at once.

Injectable preparationsNothing

A small molecule designed for oral use. Injecting it discards the one property that made it convenient and adds sterility risk.

Verdict: No advantage, added risk.

What it is claimed to do, graded

Reduces fat mass in humansNone shown

Zero human trials of any kind. Every result behind this is in mice or in cell culture.

Reduces fat mass in obese animalsModerate

Consistently demonstrated, including in combination with calorie restriction. This is real, and it is a mouse.

Rejuvenates ageing muscle stem cellsLimited

Shown in culture, in a 2019 paper. A long way from a person regaining muscle.

Raises NAD+ levels in peopleNone shown

The mechanism predicts it. Nobody has measured it in a human.

Is safe for the 8-12 week cycles people runNone shown

There is no human safety data at any duration. NNMT is also implicated in cancer biology in both directions, which makes long-term inhibition an open question rather than a formality.

Grades describe how much human evidence exists for that specific claim, not whether it will work for you or whether it is safe.

Pros and cons

Pros
  • โ€ข Orally active, so no injections
  • โ€ข The NNMT and NAD+ biology is legitimate and well published
  • โ€ข Animal data is consistent across models
  • โ€ข Reported side effects at commonly used amounts are mild and gastrointestinal
Cons
  • โ€ข Zero human trials โ€” grade F on the site's own ladder
  • โ€ข Doses people take are extrapolated from mouse work, which is not how human dosing is derived
  • โ€ข NNMT's role in cancer cuts both ways, and chronic inhibition in humans is unstudied
  • โ€ข Sold as a fat-loss agent on the strength of mouse data alone
  • โ€ข Unregulated supply with no identity or purity assurance

When to stop

  • โ€ข Gastrointestinal upset that does not settle in the first week
  • โ€ข Any new cancer diagnosis
  • โ€ข Restlessness or sleep disruption at higher doses
  • โ€ข You have run past 12 weeks โ€” there is no safety data supporting longer

Interactions

NAD+ precursors (NMN, NR, niacinamide)Monitor

Overlapping mechanism on the same pool. Combined effects are unstudied and the rationale for stacking is theoretical.

Active or suspected cancerAvoid

NNMT is implicated in tumour biology. Inhibiting it chronically in a body with a tumour is unstudied in either direction.

MetforminMonitor

Both touch cellular energy sensing. No interaction data.

A calorie deficitCompatible

The mouse work that looks best combined the inhibitor with calorie restriction, not the inhibitor alone.

Nothing well characterisedCaution

No human interaction literature exists for this compound.

Is this for you?

Probably worth reading further if
  • โ€ข People who find the NNMT biology interesting and accept they are running an experiment with no human precedent
  • โ€ข Anyone keeping cycles short because there is no data supporting long ones
Skip it if
  • โ€ข You have active cancer or a personal cancer history
  • โ€ข You are pregnant or nursing
  • โ€ข You want a fat-loss agent with human evidence
  • โ€ข You plan to run it continuously

The one number

0 indexed human-trial records; every efficacy result is in mice or cell culture
Pepdex evidence index โ€” counts are indexed PubMed records, not deduplicated trials; PubMed query for 5-amino-1MQ / NNMT inhibitor

Sources for the claims above

Community patterns

Members only
Free, no account needed

New to 5-Amino-1MQ? Grab the starter checklist.

Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.

No spam, and we never sell your email. Just the checklist. Email support@pepdex.co to opt out any time.

AI Coach, live sample
Member answer
is 250mcg of bpc enough for a knee injury?
For a knee, is the standard working dose and a solid place to start. The trick with BPC is consistency, give it weeks, not days. , run it , and don't drop below , results tend to fall off under that line. If nothing's moved by week 3, that's when earns its place.
how much bac water for a 10mg reta vial?
is the standard play for a 10 mg reta vial. That gives you , clean unit math across the whole titration: on a 100-unit insulin syringe. Run instead if you want fewer, more concentrated shots. Most people titrate up over , and that mix keeps the numbers cleanest.
what should i track on bloodwork for tirzepatide?
Lipid panel, ALT/AST (liver enzymes), and an A1C, baseline before you start then every 3 months. If you've got metabolic-syndrome history, add fasting glucose and insulin so you can actually watch insulin sensitivity improve. You don't need a big hormone panel for a GLP-1.

Numbers redacted in this preview. Members get the full answer, on their own stack.

Ask the Coach anything about 5-Amino-1MQ or your own stack. This is it working.

Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.

Unlock the full Coach, from $4.99/week โ†’

Frequently asked

What is 5-Amino-1MQ?+
5-Amino-1MQ blocks an enzyme called NNMT that gets overactive in obesity and stalls fat loss. Oral capsule. Early human data is promising but limited, best treated as a metabolic adjunct, not a hero.
Is 5-Amino-1MQ FDA approved?+
Not FDA approved. In early human trials.
Is 5-Amino-1MQ legal?+
5-Amino-1MQ is not FDA-approved, so there is no approved prescription version. Most supply is sold as "research only" by peptide vendors. A compounding pharmacy may only use substances the FDA permits for compounding, and many research peptides are not permitted โ€” do not assume a compounded prescription is available. Possession is generally not criminalized but distribution without authorization may be. Verify local laws.
Is 5-Amino-1MQ banned by WADA?+
5-Amino-1MQ is not currently on the WADA prohibited list.
Are you still natty after taking 5-Amino-1MQ?+
No. 5-Amino-1MQ is a performance-enhancing peptide and would disqualify a strict natty claim.
Do doctors prescribe 5-Amino-1MQ?+
Not prescribed in conventional medicine.
What's the typical dose of 5-Amino-1MQ?+
Dosing depends on your goal, experience, and tolerance. The full 5-Amino-1MQ protocol (dose, frequency, and how to titrate) is in the members section on the entry page.
What are the side effects of 5-Amino-1MQ?+
Common side effects include: GI upset early; Mild restlessness / energy at higher doses. Less common effects and full safety details are on the entry page.
How long until 5-Amino-1MQ starts working?+
Subtle. Some users report energy bump.
What can you stack with 5-Amino-1MQ?+
5-Amino-1MQ is commonly combined with complementary compounds. The full stacking protocol (what to pair, dosing, and timing) is in the members section on the entry page.
Where do people get 5-Amino-1MQ?+
Pepdex does not sell, ship, or recommend suppliers. 5-Amino-1MQ is not FDA-approved; prescription versions require licensed clinical care, and "research only" markets carry real legal and quality risks. /coa explains how to verify a Certificate of Analysis and /guides/scam-vendor-spotting covers the red flags.
5-Amino-1MQ vs MOTS-c, which is better?+
MOTS-c vs 5-Amino-1MQ: mitochondrial peptide vs NNMT inhibitor. Two pathways into metabolic flexibility. Full head-to-head comparison: https://pepdex.co/compare/mots-c-vs-5-amino-1mq

Common questions about 5-Amino-1MQ

Head-to-head with 5-Amino-1MQ

Compare
5-Amino-1MQ vs MOTS-c โ†’

Tracked alongside 5-Amino-1MQ

Same goal, different aisle โ€” each graded on its own evidence in the Pepdex catalog.

Whey protein โ†’
muscle preservation is the open question on any GLP-1 run
Electrolytes โ†’
appetite suppression cuts fluid and sodium intake with it
Fiber โ†’
the constipation answer that shows up in every GLP-1 thread
Metformin โ†’
the prescription neighbour people compare these protocols against

More in Fat Loss

โ„– 009
Tirzepatide

Strong weight loss with a cleaner side effect profile than semaglutide. A dual agonist (GLP-1 + GIP), FDA-approved as Mounjaro / Zepbound.

โ„– 010
Semaglutide

The original weight-loss wave, sold as Ozempic / Wegovy. A GLP-1 agonist.

โ„– 003
Retatrutide

Triple agonist (GLP-1 + GIP + glucagon) from Eli Lilly. In trials it outperforms Tirzepatide for weight loss.

โ„– 059
Liraglutide (Saxenda / Victoza)

Daily GLP-1 receptor agonist. FDA-approved 2010 (Victoza, T2D) and 2014 (Saxenda, obesity). The first wave of modern GLP-1 weight-loss therapy and direct predecessor to Semaglutide.